Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aegerion Pharmaceuticals Earnings Preview: Can This Streak Finally End?
Wall Street Cheat Street
Saturday, April 27, 2013 - 10:10am
tags:
Aegerion, earnings
Merck's Product Pipeline Could Lead To Healthy Shareholder Returns
Motley Fool
Saturday, April 27, 2013 - 10:10am
tags:
Merck
Earnings Preview: Pfizer to report Q1 results
Yahoo/AP
Saturday, April 27, 2013 - 10:09am
tags:
Pfizer, earnings
Bristol-Myers Squibb's New Drugs Can Help Reverse Its Sinking Revenue
Seeking Alpha
Saturday, April 27, 2013 - 10:08am
tags:
Bristol-Myers Squibb
U.S. Files Suit Accusing Novartis of Paying Kickbacks to Doctors
Fox Business News
Saturday, April 27, 2013 - 10:07am
tags:
Novartis, kickbacks, legal
4 Stocks Improving Performance Of The Health Care Sector
The Street
Saturday, April 27, 2013 - 10:02am
tags:
Watson Pharmaceuticals, Actavis, AstraZeneca, Merck
Anacor Prices New Stock Offering
Motley Fool
Saturday, April 27, 2013 - 10:00am
tags:
Anacor
Cempra to Present Data on Solithromycin's (CEM-101) Potential Against Urogenital Infections and Multidrug-Resistant Pathogens at ECCMID
Yahoo/PR Newswire
Saturday, April 27, 2013 - 9:59am
tags:
Cempra, Solithromycin
Teva's 3 Biggest Challenges
Motley Fool
Saturday, April 27, 2013 - 9:58am
tags:
Teva Pharmaceuticals
Vertex Pharmaceuticals: Today's Featured Drugs Laggard
The Street
Saturday, April 27, 2013 - 9:58am
tags:
Vertex Pharmaceuticals
Celgene Corporation: Today's Featured Health Care Winner
The Street
Saturday, April 27, 2013 - 9:57am
tags:
Celgene
Celgene: EU panel recommends new Revlimid approval
Yahoo/AP
Saturday, April 27, 2013 - 9:56am
tags:
Celgene
Theravance to Split After Ending Review of Alternatives
Bloomberg
Saturday, April 27, 2013 - 9:55am
tags:
Theravance
Geron Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha
Saturday, April 27, 2013 - 9:54am
tags:
Geron
Bayer Earnings Rise Y/Y
Yahoo/Zacks
Saturday, April 27, 2013 - 9:54am
tags:
Bayer
ImmunoGen's CEO Discusses F3Q 2013 Results - Earnings Call Transcript
Seeking Alpha
Saturday, April 27, 2013 - 9:53am
tags:
Immunogen
Biotech startup hustles new Alzheimer's program to the clinic
Fierce Biotech
Friday, April 26, 2013 - 11:53am
tags:
Alzheimer's disease, Targretin, Eisai, ReXceptor
Johnson & Johnson, Evotec bask in Harvard's breaking diabetes discovery
Fierce Biotech
Friday, April 26, 2013 - 11:51am
tags:
Evotec, JNJ, Harvard, diabetes
Sanofi distances itself from consultant caught up in tax fraud probe
Fierce Pharma
Friday, April 26, 2013 - 11:40am
tags:
Sanofi, tax fraud
Covidien Earnings: Everything You Must Know Now
Wall St. Cheat Sheet
Friday, April 26, 2013 - 11:39am
tags:
Covidien, devices, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.